Homocysteine thiolactone induces cardiac dysfunction: Role of oxidative stress

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 2, 2010, Pages 198-202

  Mendes, R H ^a   Sirvente, R A ^b   Candido, G O ^b   Mostarda, C ^b   Salemi, V M C ^b   D'Almeida, V ^c   Jacob, M H ^a   Ribeiro, M F ^a   Bello Klein A ^a   Rigatto, K ^a,d   Irigoyen, M C ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Antioxidant enzymes; Cardiac function; Hyperhomocysteinemia; Methionine; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; METHIONINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART DISEASE; HEART FUNCTION; HEART HEMODYNAMICS; HEART PERFORMANCE; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRANSTHORACIC ECHOCARDIOGRAPHY; ANALOGS AND DERIVATIVES; ANIMAL; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY; TOXICITY; WISTAR RAT;

ANIMALS; CARDIOVASCULAR DISEASES; HOMOCYSTEINE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 77649330300     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181ce5c28     Document Type: Article

References (34)

1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1:228-237.
2. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-246.
3. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483. (Pubitemid 34441738)
4. Carluccio MA, Ancora MA, Massaro M, et al. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: Protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol. 2007;293:H2344-H2354.
5. Walker E, Black J, Parris C, et al. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann Clin Lab Sci. 2004;34:175-180.
6. Cesari M, Zanchetta M, Burlina A, et al. Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol. 2005;25:115-121.
7. Devi S, Kennedy RH, Joseph L, et al. Effect of long-term hyperhomocysteinemia on myocardial structure and function in hypertensive rats. Cardiovasc Pathol. 2006;15:75-82.
8. Joseph J, Joseph L, Shekhawat N, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol. 2003;285:H679-H686.
9. Kassab S, Garadah T, Abu-Hijleh M, et al. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. J Renin Angiotensin Aldosterone Syst. 2006;7:206-211.
10. Sundstrom J, Sullivan L, Selhub J, et al. Relations of plasma homocysteine to left ventricular structure and function: The Framingham Heart Study. Eur Heart J. 2004;25:523-530.
11. Pexa A, Herrmann M, Taban-Shomal O, et al. Experimental hyperhomocysteinaemia: differences in tissue metabolites between homocysteine and methionine feeding in a rat model. Acta Physiol (Oxf). 2009;197: 27-34.
12. Kerkeni M, Added F, Ben Farhat M, et al. Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease. Ann Clin Biochem. 2008;45:193-198.
13. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3:1646-1654.
14. Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr. 2006;136(Suppl 6):S1741-S1749.
15. Maron BA, Loscalzo J.The treatment of hyperhomocysteinemia. Annu Rev Med. 2008;60:39-54.
16. Moshal KS, Metreveli N, Frank I, et al. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol. 2008;6:84-92.
17. De Oliveira AC, D'Almeida V, Hipolide DC, et al. Sleep deprivation reduces total plasma homocysteine levels in rats. Can J Physiol Pharmacol. 2002;80:193-197.
18. Llesuy SF, Milei J, Molina H, et al. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4'-epiadriamycin in mice. Tumori. 1985;71:241-249.
19. Gonzalez Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med. 1991;10:93-100.
20. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
21. Marklund S. Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: CRC Press; 1985:243-247.
22. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
23. Mannervik B, Guthenberg C. Glutathione transferase (human placenta). Methods Enzymol. 1981;77:231-235.
24. Klein D, Kern RM, Sokol RZ. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int. 1995;36:59-66.
25. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
26. Miller JW, Nadeau MR, Smith D, et al. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr. 1994;59:1033-1039.
27. Nightingale AK, James PP, Morris-Thurgood J, et al. Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model. Am J Physiol Heart Circ Physiol. 2001;280:H1334-H1339.
28. Resstel LB, De Andrade CR, Haddad R, et al. Hyperhomocysteinaemiainduced cardiovascular changes in rats. Clin Exp Pharmacol Physiol. 2008;35:1-8.
29. Nasir K, Tsai M, Rosen BD, et al. Elevated homocysteine is associated with reduced regional left ventricular function: The Multi-Ethnic Study of Atherosclerosis. Circulation. 2007;115:180-187. (Pubitemid 46105716)
30. Chen P, Poddar R, Tipa EV, et al. Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv Enzyme Regul. 1999;39: 93-109.
31. Wang L, Lopaschuk GD, Clanachan AS. H(2)O(2)-induced left ventricular dysfunction in isolated working rat hearts is independent of calcium accumulation. J Mol Cell Cardiol. 2008;45:787-795.
32. Diez N, Perez R, Hurtado V, et al. Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats. Br J Nutr. 2005;94:204-210.
33. Antoniades C, Antonopoulos AS, Tousoulis D, et al. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6-15.
34. Loch T, Vakhrusheva O, Piotrowska I, et al. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovasc Res. 2009;82:448-1445